Polly A. Murphy - 21 Jun 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVIR	Restricted Stock Units	Award	$0	+29,600		$0	29,600	21 Jun 2024	Common Stock	29,600		Direct	F1, F2
transaction	AVIR	Stock Option (Right to Buy)	Award	$0	+41,200		$0	41,200	21 Jun 2024	Common Stock	41,200	$3.44	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
F3	The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.